Send to

Choose Destination
Lancet Infect Dis. 2019 Nov;19(11):1161-1162. doi: 10.1016/S1473-3099(19)30545-6.

A necessary discussion after transmission of multidrug-resistant organisms through faecal microbiota transplantations.

Author information

Department of Medical Microbiology, Center for Infectious Diseases, Leiden University Medical Center, 2333 ZA Leiden, Netherlands; National Donor Feces Bank, Leiden University Medical Center, 2333 ZA Leiden, Netherlands. Electronic address:
Division of Gastroenterology, Hepatology, and Endoscopy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Institute of Microbiology and Infection, University of Birmingham, Birmingham, UK.
Sorbonne Université, Inserm, Centre de Recherche Saint-Antoine, Hôpital Saint Antoine, Service de Gastroenterologie, Paris, France; French Group of Faecal Microbiota Transplantation, Paris, France.
Centre for Clinical Infection and Diagnostics Research, King's College London and Guy's and St Thomas' NHS Foundation Trust, London, UK.
Digestive Disease Center, Fondazione Policlinico Universitario A Gemelli, Università Cattolica del Sacro Cuore, Rome, Italy.
Department of Internal Medicine, Division of Gastroenterology and Hepatology, Medical University Graz, Graz, Austria.
Department of Gastroenterology, Queen Elizabeth Hospital, Adelaide, SA, Australia.
National Donor Feces Bank, Leiden University Medical Center, 2333 ZA Leiden, Netherlands; Department of Gastroenterology, Haaglanden Medical Center, Den Haag, Netherlands.
Department I of Internal Medicine, University of Cologne, Cologne, Germany; Center for Integrated Oncology Aachen-Bonn-Cologne-Duesseldorf, Cologne, Germany; German Centre for Infection Research, partner site Bonn-Cologne, Germany; Department of Internal Medicine and Infectious Diseases, Goethe University Frankfurt, Frankfurt am Main, Germany.

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center